Overland Park, Kansas — Rapamycin, a drug traditionally used to prevent organ rejection after transplants, is increasingly drawing attention in the realm of anti-aging research. Originally developed as an immunosuppressant, the drug’s potential to slow aging and extend lifespan has become the focus of numerous studies in recent years. With mounting evidence suggesting that rapamycin […]